Skip to main content

Table 1 Demographic, laboratory, and imaging data of studied population

From: Hepatic resection versus microwave ablation for the treatment of early hepatocellular carcinoma: a comparative analysis of treatment outcomes and survival predictors

  Total (N = 72) Hepatectomy group (N = 31) Microwave group (N = 41) P value
Demographic data (Count/%)
Age 60.24 (8.07) 57.81 62.07 0.029
Gender (male/female) 49 (68.1%)/23 (31.9%) 23 (74.2%)/8 (25.8%) 26 (63.4%)/15 (36.6%) 0.331
BMI (mean/SD) 29.08 (3.86) 29.23 (3.98) 28.97 (3.81) 0.741
Smoking 19 (26.4%) 9 (29%) 10 (24.4%) 0.658
Diabetes mellitus 23 (31.9%) 10 (32.2%) 13 (31.7%) 0.960
Previous DAAs therapy 17 (23.6%) 8 (25.8%) 9 (22%) 0.703
Laboratory data (mean/SD)
Hemoglobin 14.32 (11.45) 16.02 (17.34) 13.03 (1.78) 0.759
Leucocytic count 6.48 (2.04) 6.24 (1.65) 6.67 (2.29) 0.698
Platelets 163.89 (45.94) 175.68 (38.73) 154.98 (49.31) 0.070
Total bilirubin 1.02 (0.49) 0.90 (0.39) 1.11 (0.53) 0.151
ALT 63.74 (52.5) 55.68 (45.08) 69.83 (57.27) 0.209
AST 59.17 (45.65) 49.81 (28.42) 66.24 (54.53) 0.381
Albumin 3.54 (0.52) 3.49 (0.5) 3.58 (0.54) 0.698
Creatinine 0.90 (0.26) 0.89 (0.31) 0.91 (0.22) 0.939
INR 1.40 (1.18) 1.50 (1.77) 1.33 (0.33) 0.101
AFP (baseline) (median/IQR) 43.0 (12.30–125.00) 77 (31.3–136.0) 21 (6.7–54) 0.024
AFP (post-treatment) (median/IQR) 13.7 (6.9–43.5) 18.8 (12.6–76.40) 11.9 (6.4–18.3) 0.003
Scores (count/%)
Child Pugh score A 65 (90.3%) 0 (0%) 4 (9.8%) 0.129
B 7 (9.7%) 31 (100%) 37 (90.2%)
BCLC 0 4 (5.6%) 28 (90.3%) 37 (90.2%) 0.99
A 68 (94.4%) 3 (9.7%) 4 (9.8%)
Imaging data (count/%)
Site of HFLs Right lobe 58 (80.6%) 21 (67.7%) 37 (90.2%) 0.069
Left lobe 10 (13.9%) 7 (22.6%) 3 (7.3%)
Both lobes 4 (5.6%) 3 (9.7%) 1 (2.5%)
Focal lesion size or size of largest lesion if 2 or multiple (mean/SD) 3.20 (1.03) 3.77 (0.97) 2.78 (0.87)  < 0.001
Number of focal lesions Single 62 (86.1%) 1.29 (0.59) 1.07 (0.26) 0.058
Two 8 (11.1%)
Multiple (three or more) 2 (2.8%)